Search

Your search keyword '"Eli Lilly and Co. -- Investigations"' showing total 226 results
Start Over Descriptor "Eli Lilly and Co. -- Investigations"
226 results on '"Eli Lilly and Co. -- Investigations"'

1. A federal statue is allowing unvetted Ozempic knockoffs to flood the market; FDA 'blind spot' grants reproduction of drugs in shortages -- creating $1bn market of unbranded weight-loss drugs

Subjects
Eli Lilly and Co. -- Investigations, Novo Nordisk A/S -- Investigations, United States. Food and Drug Administration -- Investigations, Ozempic (Medication), Mounjaro (Medication), Wegovy (Medication), Zepbound (Medication), Investigations, Company legal issue, Product shortage, Mediation -- Investigations, Shortages -- Investigations, Drugs -- Investigations, Pharmacy -- Investigations, Anti-obesity agents -- Investigations, Drugstores -- Investigations, Weight loss -- Investigations, Semaglutide -- Investigations, Weight reducing preparations -- Investigations
Published
2024

2. Redwire: Lilly investigation yields 'exciting' results for drug discovery

Subjects
Eli Lilly and Co. -- Investigations, Drug discovery -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, News, opinion and commentary
Abstract

Redwire (RDW) said in a statement: In November 2023, Redwire and Eli Lilly and Company (LLY) teamed up for the first spaceflight investigation using Redwire's PIL-BOX, a unique platform that [...]

Published
2024

3. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, AGR, SHCR, DRQ on Behalf of Shareholders

Subjects
Avangrid Inc. -- Investigations, Iberdrola S.A. -- Investigations, Eli Lilly and Co. -- Investigations, Dril-Quip Inc. -- Investigations, Law firms -- Investigations, Electric utilities -- Investigations, Oil and gas field equipment industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2024

5. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, HUDA, ALE, DOMA on Behalf of Shareholders

Subjects
ALLETE Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Electric utilities -- Investigations, Securities law -- Investigations, Securities offerings -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, international, Law
Abstract

(GlobeNewswire) - Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders [...]

Published
2024

6. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, AUGX, TELL on Behalf of Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2024

8. MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2024

9. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, PRMW, SGE on Behalf of Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following press release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2024

10. Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders

Subjects
Boeing Co. -- Investigations, Eli Lilly and Co. -- Investigations, Spirit AeroSystems Holdings Inc. -- Investigations, Law firms -- Investigations, Aircraft industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Aircraft equipment and supplies industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLC has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2024

11. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders

Subjects
Boeing Co. -- Investigations, Eli Lilly and Co. -- Investigations, Spirit AeroSystems Holdings Inc. -- Investigations, Law firms -- Investigations, Securities law -- Investigations, Aircraft industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Aircraft equipment and supplies industry -- Investigations, Company legal issue, Business, international, Law
Abstract

(GlobeNewswire) - Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders [...]

Published
2024

12. Halper Sadeh LLC Investigates MORF, DM on Behalf of Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLC has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2024

13. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders

Subjects
Infinera Corp. -- Investigations, Nokia Corp. -- Investigations, Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Telecommunications equipment industry -- Investigations, Securities law -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Telecommunications equipment industry, Business, international, Law
Abstract

(GlobeNewswire) - Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders [...]

Published
2024

14. MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2024

15. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

Subjects
Avangrid Inc. -- Investigations, Iberdrola S.A. -- Investigations, ANI Pharmaceuticals Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Electric utilities -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, international, Law
Abstract

(GlobeNewswire) - Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at [...]

Published
2024

17. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

Subjects
Avangrid Inc. -- Investigations, Iberdrola S.A. -- Investigations, ANI Pharmaceuticals Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Electric utilities -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

BALA CYNWYD, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason [...]

Published
2024

18. MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW YORK -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Morphic Holding, Inc. (NASDAQ: MORF) to Eli Lilly and Company for $57.00 per [...]

Published
2024

19. MORF Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

MONSEY, N.Y., July 08, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Morphic Holding, Inc. (Nasdaq: MORF) [...]

Published
2024

20. EC Antitrust Enforcers Investigating Maker Of Leading Pain Medicine For Dogs

Subjects
Merck & Company Inc. -- Investigations, Bayer AG -- Investigations, Boehringer Ingelheim GmbH -- Investigations, Eli Lilly and Co. -- Investigations, Antitrust law -- Investigations, Chronic pain -- Investigations, Biological products -- Investigations, Pain -- Care and treatment, Analgesics -- Investigations, Monoclonal antibodies -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Antitrust issue, Business, international, European Union. European Commission -- Investigations
Abstract

EC Concerned Company Blocked Competing Product The European Commission has opened a formal antitrust investigation to assess whether animal health company Zoetis may have breached EU competition rules by preventing [...]

Published
2024

21. Research Conducted at Eli Lilly and Company Has Updated Our Knowledge about Immunoglobulins (Investigation of Immune Responses To Oxidation, Deamidation, and Isomerization In Therapeutic Antibodies Using Preclinical Immunogenicity Risk ...)

Subjects
Eli Lilly and Co. -- Investigations, Health aspects, Investigations, Company legal issue, Physical fitness -- Investigations -- Health aspects, Oxidation-reduction reactions -- Health aspects -- Investigations, Isomerization -- Investigations -- Health aspects, Biopharmaceuticals -- Health aspects -- Investigations, Pharmaceutical industry -- Health aspects -- Investigations, Immune response -- Investigations -- Health aspects, Immunoglobulins -- Investigations -- Health aspects, Biopharmaceutics -- Health aspects -- Investigations, Oxidation-reduction reaction -- Health aspects -- Investigations
Abstract

2022 SEP 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Immunology - Immunoglobulins. According to news originating [...]

Published
2022

22. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ('POINT') [...]

Published
2023

23. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ('POINT') [...]

Published
2023

24. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ('POINT') (NASDAQ: PNT) breached their fiduciary duties [...]

Published
2023

25. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Stakeholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ('POINT') [...]

Published
2023

26. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Johnson Fistel, LLP has issued the following news release: Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma [...]

Published
2023

27. POINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Investor relations -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of POINT Biopharma Global, Inc. ('POINT') [...]

Published
2023

28. POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW ORLEANS: Kahn Swick & Foti, LLC has issued the following news release: Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick [...]

Published
2023

29. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PNT, RENB, KITT, APRN

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Securities law -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Registered nurses -- Investigations, Company legal issue, Business, international, Law
Abstract

(GlobeNewswire) - Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders [...]

Published
2023

30. POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2023

31. PNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of POINT Biopharma Global, Inc. Is Fair to Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: HALPER SADEH LLC has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of POINT Biopharma Global, Inc. (NASDAQ: [...]

Published
2023

32. Shareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

MILWAUKEE: Ademi LLP has issued the following news release: Ademi LLP is investigating POINT (Nasdaq: PNT) for possible breaches of fiduciary duty and other violations of law in its transaction [...]

Published
2023

33. PNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of POINT Biopharma Global, Inc. Is Fair to Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW YORK -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of POINT Biopharma Global, Inc. (NASDAQ: PNT) to Eli Lilly for $12.50 per share [...]

Published
2023

34. Shareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly

Subjects
Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, News, opinion and commentary
Abstract

MILWAUKEE, Oct. 3, 2023 /PRNewswire/ -- Ademi LLP is investigating POINT (Nasdaq: PNT) for possible breaches of fiduciary duty and other violations of law in its transaction with Eli Lilly. [...]

Published
2023

35. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc. (Nasdaq - VERY), POINT Biopharma Global, Inc. (Nasdaq - PNT), Blue Apron Holdings, Inc. (Nasdaq - APRN), Chico's FAS, Inc. (NYSE - CHS)

Subjects
iA Financial Corporation Inc. -- Investigations, Chico's FAS Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Biological products industry -- Investigations, Clothing stores -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Registered nurses -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

BALA CYNWYD, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason [...]

Published
2023

36. SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2023

37. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE -- AEL), Amedisys, Inc. (Nasdaq -- AMED), Sigilon Therapeutics, Inc (Nasdaq -- SGTX)

Subjects
Amedisys Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Holding companies -- Investigations, Health care industry -- Investigations, Insurance industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Health care industry, Company legal issue, Insurance industry, Business, international, Law
Abstract

(GlobeNewswire) - Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at [...]

Published
2023

38. BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE - AEL), Amedisys, Inc. (Nasdaq - AMED), Sigilon Therapeutics, Inc (Nasdaq - SGTX)

Subjects
Amedisys Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Holding companies -- Investigations, Health care industry -- Investigations, Insurance industry -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Health care industry, Company legal issue, Insurance industry, Banking, finance and accounting industries, Business
Abstract

BALA CYNWYD, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason [...]

Published
2023

39. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM

Subjects
Mortgage Capital Corp. -- Investigations, Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2023

40. SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sigilon Therapeutics, Inc (Nasdaq -- SGTX)

Subjects
Eli Lilly and Co. -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, international, Law
Abstract

(GlobeNewswire) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Sigilon Therapeutics, Inc. (Sigilon or the Company) (Nasdaq SGTX) [...]

Published
2023

41. SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sigilon Therapeutics, Inc (Nasdaq - SGTX)

Subjects
Eli Lilly and Co. -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Banking, finance and accounting industries, Business
Abstract

BALA CYNWYD, Pa., July 12, 2023 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Sigilon Therapeutics, [...]

Published
2023

42. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DICE, QUOT, TALS, CFMS

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2023

43. SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGTX, AMED, FRG, DHC

Subjects
Amedisys Inc. -- Investigations, Franchise Group Inc. -- Investigations, Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2023

44. DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE (Updated on July 10, 2023)

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW ORLEANS: KAHN SWICK & FOTI, LLC has issued the following news release: Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick [...]

Published
2023

45. DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2023

46. SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW ORLEANS: KAHN SWICK & FOTI, LLC has issued the following news release: Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick [...]

Published
2023

47. IMPORTANT ALERT: Halper Sadeh LLC Investigates WMC, SGTX, PRTK

Subjects
Paratek Pharmaceuticals Inc. -- Investigations, Mortgage Capital Corp. -- Investigations, Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

NEW YORK: Halper Sadeh LLP has issued the following news release: Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal [...]

Published
2023

48. Shareholder Alert: Ademi LLP investigates whether Sigilon Therapeutics, Inc. has obtained a Fair Price in its transaction with Eli Lilly

Subjects
Eli Lilly and Co. -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, General interest, News, opinion and commentary
Abstract

MILWAUKEE: Ademi LLP has issued the following news release: Ademi LLP is investigating Sigilon (Nasdaq: SGTX) for possible breaches of fiduciary duty and other violations of law in its transaction [...]

Published
2023

49. SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX

Subjects
Eli Lilly and Co. -- Investigations, Attorneys general -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW ORLEANS -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of [...]

Published
2023

50. SGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to Shareholders

Subjects
Eli Lilly and Co. -- Investigations, Law firms -- Investigations, Stockholders -- Investigations, Pharmaceutical industry -- Investigations, Company legal issue, Business, Business, international
Abstract

NEW YORK -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Sigilon Therapeutics, Inc. (NASDAQ: SGTX) to Eli Lilly and Company is fair to [...]

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results